A citation-based method for searching scientific literature

D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
Times Cited: 181







List of co-cited articles
577 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
35

Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
159
27



The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
348
22


Attitudes toward presymptomatic testing in Huntington disease.
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
127
19

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
434
19

Self-selection in predictive testing for Huntington's disease.
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
115
17

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
184
17


Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
183
17

A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
16

Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
104
16


Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
263
15

Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.
E S Tambor, B A Bernhardt, G A Chase, R R Faden, G Geller, K J Hofman, N A Holtzman. Am J Hum Genet 1994
135
15




On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
95
13



Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
176
13

Predictors of psychological adjustment to genetic testing for Huntington's disease.
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
64
20


A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
12



Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
128
11

One hundred requests for predictive testing for Huntington's disease.
S A Simpson, J Besson, D Alexander, K Allan, A W Johnston. Clin Genet 1992
37
29

The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
139
11


Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
104
11

Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
69
14

Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
84
11

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
243
10

Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
124
10

Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.
S Adam, S Wiggins, P Whyte, M Bloch, M H Shokeir, H Soltan, W Meschino, A Summers, O Suchowersky, J P Welch. J Med Genet 1993
75
13




Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.
S Creighton, E W Almqvist, D MacGregor, B Fernandez, H Hogg, J Beis, J P Welch, C Riddell, R Lokkesmoe, M Khalifa,[...]. Clin Genet 2003
114
10

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
9



Uptake of genetic testing for cancer predisposition.
D G Evans, E R Maher, R Macleod, D R Davies, D Craufurd. J Med Genet 1997
53
16

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
9

Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
156
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.